Report Detail

Other Global Parkinson’s Disease Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • RnM3812873
  • |
  • 11 October, 2019
  • |
  • Global
  • |
  • 122 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Global Parkinson’s Disease Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

    1 Parkinson’s Disease Treatment Market Overview

    • 1.1 Product Overview and Scope of Parkinson’s Disease Treatment
    • 1.2 Classification of Parkinson’s Disease Treatment by Types
      • 1.2.1 Global Parkinson’s Disease Treatment Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Parkinson’s Disease Treatment Revenue Market Share by Types in 2018
      • 1.2.3 Oral
      • 1.2.4 Transdermal
      • 1.2.5 Subcutaneous
      • 1.2.6 Intestinal Infusion
    • 1.3 Global Parkinson’s Disease Treatment Market by Application
      • 1.3.1 Global Parkinson’s Disease Treatment Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Hospital Pharmacy
      • 1.3.3 Retail Pharmacy
      • 1.3.4 Online Pharmacy
    • 1.4 Global Parkinson’s Disease Treatment Market by Regions
      • 1.4.1 Global Parkinson’s Disease Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Parkinson’s Disease Treatment Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Parkinson’s Disease Treatment Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Parkinson’s Disease Treatment Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Parkinson’s Disease Treatment Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Parkinson’s Disease Treatment Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Parkinson’s Disease Treatment (2014-2024)

    2 Company Profiles

    • 2.1 UCB
      • 2.1.1 Business Overview
      • 2.1.2 Parkinson’s Disease Treatment Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 UCB Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 AbbVie
      • 2.2.1 Business Overview
      • 2.2.2 Parkinson’s Disease Treatment Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 AbbVie Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Acorda Therapeutics
      • 2.3.1 Business Overview
      • 2.3.2 Parkinson’s Disease Treatment Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Acorda Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Roche
      • 2.4.1 Business Overview
      • 2.4.2 Parkinson’s Disease Treatment Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Roche Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Teva
      • 2.5.1 Business Overview
      • 2.5.2 Parkinson’s Disease Treatment Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Teva Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Prothena
      • 2.6.1 Business Overview
      • 2.6.2 Parkinson’s Disease Treatment Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Prothena Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Orion Pharmaceuticals
      • 2.7.1 Business Overview
      • 2.7.2 Parkinson’s Disease Treatment Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Orion Pharmaceuticals Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Impax Pharmaceuticals
      • 2.8.1 Business Overview
      • 2.8.2 Parkinson’s Disease Treatment Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Impax Pharmaceuticals Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Voyager Therapeutics
      • 2.9.1 Business Overview
      • 2.9.2 Parkinson’s Disease Treatment Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Voyager Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 MSD
      • 2.10.1 Business Overview
      • 2.10.2 Parkinson’s Disease Treatment Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 MSD Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Sunovion
      • 2.11.1 Business Overview
      • 2.11.2 Parkinson’s Disease Treatment Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Sunovion Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Intec Pharma
      • 2.12.1 Business Overview
      • 2.12.2 Parkinson’s Disease Treatment Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Intec Pharma Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 GSK
      • 2.13.1 Business Overview
      • 2.13.2 Parkinson’s Disease Treatment Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 GSK Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Acadia
      • 2.14.1 Business Overview
      • 2.14.2 Parkinson’s Disease Treatment Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Acadia Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 NeuroDerm
      • 2.15.1 Business Overview
      • 2.15.2 Parkinson’s Disease Treatment Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 NeuroDerm Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.16 Adamas Therapeutics
      • 2.16.1 Business Overview
      • 2.16.2 Parkinson’s Disease Treatment Type and Applications
        • 2.16.2.1 Product A
        • 2.16.2.2 Product B
      • 2.16.3 Adamas Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Parkinson’s Disease Treatment Market Competition, by Players

    • 3.1 Global Parkinson’s Disease Treatment Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Parkinson’s Disease Treatment Players Market Share
      • 3.2.2 Top 10 Parkinson’s Disease Treatment Players Market Share
    • 3.3 Market Competition Trend

    4 Global Parkinson’s Disease Treatment Market Size by Regions

    • 4.1 Global Parkinson’s Disease Treatment Revenue and Market Share by Regions
    • 4.2 North America Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
    • 4.5 South America Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)

    5 North America Parkinson’s Disease Treatment Revenue by Countries

    • 5.1 North America Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
    • 5.2 USA Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)

    6 Europe Parkinson’s Disease Treatment Revenue by Countries

    • 6.1 Europe Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
    • 6.2 Germany Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
    • 6.3 UK Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
    • 6.4 France Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Parkinson’s Disease Treatment Revenue by Countries

    • 7.1 Asia-Pacific Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
    • 7.2 China Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
    • 7.5 India Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)

    8 South America Parkinson’s Disease Treatment Revenue by Countries

    • 8.1 South America Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
    • 8.2 Brazil Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Parkinson’s Disease Treatment by Countries

    • 9.1 Middle East and Africa Parkinson’s Disease Treatment Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Parkinson’s Disease Treatment Revenue and Growth Rate (2014-2019)

    10 Global Parkinson’s Disease Treatment Market Segment by Type

    • 10.1 Global Parkinson’s Disease Treatment Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Parkinson’s Disease Treatment Market Forecast by Type (2019-2024)
    • 10.3 Oral Revenue Growth Rate (2014-2024)
    • 10.4 Transdermal Revenue Growth Rate (2014-2024)
    • 10.5 Subcutaneous Revenue Growth Rate (2014-2024)
    • 10.6 Intestinal Infusion Revenue Growth Rate (2014-2024)

    11 Global Parkinson’s Disease Treatment Market Segment by Application

    • 11.1 Global Parkinson’s Disease Treatment Revenue Market Share by Application (2014-2019)
    • 11.2 Parkinson’s Disease Treatment Market Forecast by Application (2019-2024)
    • 11.3 Hospital Pharmacy Revenue Growth (2014-2019)
    • 11.4 Retail Pharmacy Revenue Growth (2014-2019)
    • 11.5 Online Pharmacy Revenue Growth (2014-2019)

    12 Global Parkinson’s Disease Treatment Market Size Forecast (2019-2024)

    • 12.1 Global Parkinson’s Disease Treatment Market Size Forecast (2019-2024)
    • 12.2 Global Parkinson’s Disease Treatment Market Forecast by Regions (2019-2024)
    • 12.3 North America Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
    • 12.4 Europe Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
    • 12.6 South America Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Parkinson’s Disease Treatment Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Scope of the Report:
      The global Parkinson’s Disease Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Parkinson’s Disease Treatment.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Parkinson’s Disease Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Parkinson’s Disease Treatment market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      UCB
      AbbVie
      Acorda Therapeutics
      Roche
      Teva
      Prothena
      Orion Pharmaceuticals
      Impax Pharmaceuticals
      Voyager Therapeutics
      MSD
      Sunovion
      Intec Pharma
      GSK
      Acadia
      NeuroDerm
      Adamas Therapeutics

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Oral
      Transdermal
      Subcutaneous
      Intestinal Infusion

      Market Segment by Applications, can be divided into
      Hospital Pharmacy
      Retail Pharmacy
      Online Pharmacy


      Summary:
      Get latest Market Research Reports on Parkinson’s Disease Treatment. Industry analysis & Market Report on Parkinson’s Disease Treatment is a syndicated market report, published as Global Parkinson’s Disease Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Parkinson’s Disease Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,787.27
      4,180.90
      5,574.54
      3,156.44
      4,734.65
      6,312.87
      376,779.60
      565,169.40
      753,559.20
      247,143.34
      370,715.00
      494,286.67
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report